2022Recent advances in anesthesiologyRequires access

Uterotonic Agents

Juan José Correa Barrera, Blanca Gómez del Pulgar Vázquez, Adriana Orozco Vinasco, Enrique Alonso Rodríguez

Open publisher page 0 citations

Abstract

Postpartum haemorrhage due to uterine atony is one of the major causes of maternal morbidity and mortality worldwide. Different control strategies have been postulated, especially during the third stage of labour, but the gold standard treatment is the use of uterotonic drugs. There are currently three well-defined groups of drugs: oxytocics, ergot derivatives and prostaglandins. Although the literature is heterogeneous, it is clear that oxytocin is the uterotonic of choice in both prophylaxis and treatment of postpartum haemorrhage. Detailed knowledge of protocols based on current evidence is mandatory, which vary according to the different medical societies and dictate the doses and order of administration of different drugs.

About this research paper

What this paper is about

Postpartum haemorrhage due to uterine atony is one of the major causes of maternal morbidity and mortality worldwide. Different control strategies have been postulated, especially during the third stage of labour, but the gold standard treatment is the use of uterotonic drugs. There are currently three well-defined groups of drugs: oxytocics, ergot derivatives and prostaglandins. Although the literature is heterogeneous, it is clear that oxytocin is the uterotonic of choice in both prophylaxis and treatment of postpartum haemorrhage. Detailed knowledge of protocols based on current evidence is mandatory, which vary according to the different medical societies and dictate the doses and order of administration of different drugs.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Postpartum haemorrhage due to uterine atony is one of the major causes of maternal morbidity and mortality worldwide. Different control strategies have been postulated, especially during the third stage of labour, but the gold standard treatment is the use of uterotonic drugs. There are currently three well-defined groups of drugs: oxytocics, ergot derivatives and prostaglandins. Although the literature is heterogeneous, it is clear that oxytocin is the uterotonic of choice in both prophylaxis and treatment of postpartum haemorrhage. Detailed knowledge of protocols based on current evidence is mandatory, which vary according to the different medical societies and dictate the doses and order of administration of different drugs.

Key concepts: Uterotonic, Uterine atony, Medicine, Oxytocin, Postpartum haemorrhage, Third stage, Intensive care medicine, Obstetrics

Related papers

Back to paper searchBrowse research topicsOriginal source
Uterotonic Agents — Research Paper | ScholarLens